Automated Analyzers Market is driven by increasing demand for diagnostics products
The automated analyzers market comprises systems designed to perform clinical chemistry and immunoassay testing automatically. Automated analyzers help in performing a wide range of tests using small sample volumes to obtain analytical results. These systems offer several advantages over manual methods, including minimal training requirements, continuous operation capability, and reduced risks of procedural errors. The growing incidence of chronic and infectious diseases is increasing the demand for diagnostic testing, driving the need for automated analyzers.
The global automated analyzers market is estimated to be valued at US$ 5.56 Bn in 2024 and is expected to exhibit a CAGR of 9.9% over the forecast period 2024 to 2031.
Key Takeaways
Key players: Key players operating in the automated analyzers market are Abbott, Danaher, Thermo Fisher Scientific, Inc., Becton Dickinson, Agilent Technologies, Inc., Zimed Healthcare Inc., Biobase Biodusty(Shandong), Co., Ltd., Chongqing Drawell Instrument CO,.Ltd, Transasia Bio-Medicals, Awareness Technology, Inc., Trivitron Healthcare, Getein Biotech, Inc., Eppendorf AG, Honeywell International, Inc., Aurora Biomed, HORIBA, Ltd., Beckman Coulter, Inc. These players are focusing on new product development and mergers & acquisitions to strengthen their Automated Analyzers Market Size position.
Growing demand: The rising disease burden of chronic diseases such as cancer and diabetes is fueling diagnostic testing volumes. This is increasing the demand for automated analyzers worldwide. Additionally, the need for continuous systems that can process high sample volumes with minimal manual intervention is propelling the automated analyzers market.
Get More Insights On- Automated Analyzers Market Size
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian